Intellia Therapeutics
NTLA
NTLA
112 hedge funds and large institutions have $467M invested in Intellia Therapeutics in 2017 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 41 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
32% more funds holding
Funds holding: 85 → 112 (+27)
18.4% more ownership
Funds ownership: 48.95% → 67.35% (+18%)
6% more capital invested
Capital invested by funds: $439M → $467M (+$27.9M)
Holders
112
Holding in Top 10
2
Calls
$5.29M
Puts
$2.98M
Top Buyers
| 1 | +$21.9M | |
| 2 | +$20.7M | |
| 3 | +$19.3M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$18.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.2M |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$6.24M | |
| 3 | -$2.99M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.82M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
-$991K |